AROVELLA THERAPEUTICS LIMITED - Charts / Financials

1.01%

9.8¢

Market Cap $116.4M

Healthcare Biotechnology

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

REFRESH

Day
Open	10.0¢		Day High	10.0¢		Day Low	9.8¢
Daily Volume	312866

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
5	9.8¢	185015		1	10.0¢	174166

Directors & Senior Management

Mr. Michael Baker	Chief Executive Officer, Managing Director, Director
Mr. Tim Luscombe	Chief Financial Officer, Company Secretary
Dr. Nicole van Der Weerden	Chief Operating Officer
Dr. Elizabeth Stoner	Non-Executive Chairman of the Board
Dr. Debora Barton	Non-Executive Independent Director
Mr. Gary Jonathan Phillips	Independent Non-Executive Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 9.8¢		Change -0.001(1.01%)		Mkt cap ! $116.4M

Open	High	Low	Value	Volume
10.0¢	10.0¢	9.8¢	$31.07K	312.8K

Buyers (Bids)

No.	Vol.	Price($)
5	185015	9.8¢

Sellers (Offers)

Price($)	Vol.	No.
10.0¢	174166	1

View Market Depth

No.	Vol.	Price($)
5	185015	0.098
3	139164	0.097
1	105000	0.096
2	163994	0.095
1	15000	0.094

Price($)	Vol.	No.
0.100	174166	1
0.105	406489	4
0.110	435258	4
0.115	86947	1
0.120	243648	9

Last trade - 16.10pm 31/07/2025 (20 minute delay)

ALA (ASX) Chart

AROVELLA THERAPEUTICS LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories